Achillion stock plunges as FDA maintains clinical hold on hep C drug
(Reuters) - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration decided not to lift a clinical hold it had placed on the firm's h...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/J71E-vnQIQg/story01.htm
No comments:
Post a Comment